Effects of Immune System-Related Medications on COVID-19 Outcome in a Cohort of Iranian Patients: Preliminary Report of a Data Mining Study면역 체계 관련 약물이 이란 환자 집단에서 COVID-19 결과에 미치는 영향: 데이터 마이닝 연구의 예비 보고서Research Article Published on 2021-07-022022-09-10 Journal: Journal of Immunology Research [Category] SARS, 치료제, [키워드] 95% CI 95% confidence interval 95%CI age antivirals association can be used clinics Cohort condition coronavirus disease Coronavirus disease 2019 Corticosteroid Corticosteroids COVID-19 Critical death Effect Evidence failure hospital Hydroxychloroquine hyperactivity ICU admission immune immune system in some incidence rate Interaction interactions Iran latent variables Logistic regression LOS Medical Sciences medication Mortality Odds ratio oseltamivir outcome Patient Poisson regression Prednisolone rate ratio reduce mortality reduction report Result risk factor Tehran Treatment university variable Viral viral infections was increased was performed was used [DOI] 10.1155/2021/9934134 PMC 바로가기 [Article Type] Research Article
Renin-Angiotensin System Blockers and the Risk of COVID-19-Related Mortality in Patients with Kidney FailureObservational Study Published on 2021-07-012022-10-05 Journal: Clinical journal of the American Society of Nephro [Category] SARS, 임상, [키워드] 28-day mortality 95% CI 95% confidence interval ACEi/ARB adjusted adjusted hazard ratio Admission affected angiotensin-converting enzyme inhibitor ARB ARBs association blocker both group calculate Comorbidities coronavirus disease COVID-19 database deleterious effect demographics diagnosis of COVID-19 dialysis died European evaluated failure hazard ratio higher risk Hospital admission information initial intensive care kidney Kidney failure kidney transplant recipient Kidney transplantation Mortality mortality risk outcome Participants Patient patients receptor recipient recipients renin angiotensin system retrieved risk severe COVID-19 severity severity of COVID-19 statistically significant subgroup Support System the patient ventilator with COVID-19 [DOI] 10.2215/CJN.18961220 PMC 바로가기 [Article Type] Observational Study
Failure of Anticoagulation to Prevent Stroke in Context of Lupus-Associated Anti-Phospholipid Syndrome and Mild COVID-19루푸스 관련 항인지질 증후군 및 경증 COVID-19의 맥락에서 뇌졸중을 예방하기 위한 항응고 요법의 실패Case Reports Published on 2021-07-012022-09-11 Journal: Journal of stroke and cerebrovascular diseases : t [Category] MERS, 바이오마커, 진단, [키워드] Anti-phospholipid anticoagulation Clinical significance Context COVID-19 COVID-19 infection dysfunction Endothelial cell event failure feature female hypercoagulability hypercoagulable Hypercoagulable state Infection Ischemic Stroke lupus erythematosus Mild pathology Patient phospholipid SARS-CoV-2 virus SARS-CoV-2 virus infection stroke subtype syndrome systemic anticoagulation systemic lupus erythematosus the SARS-CoV-2 virus therapeutic anticoagulation thromboembolic Thromboembolic event Thromboembolic events vascular inflammation virus infection with COVID-19 [DOI] 10.1016/j.jstrokecerebrovasdis.2021.105817 PMC 바로가기 [Article Type] Case Reports
Could Dapagliflozin Attenuate COVID-19 Progression in High-Risk Patients With or Without Diabetes? Behind DARE-19 Concept다파글리플로진은 당뇨병이 있거나 없는 고위험 환자에서 COVID-19 진행을 약화시킬 수 있습니까? DARE-19 개념 뒤에Review Published on 2021-07-012022-09-11 Journal: Journal of cardiovascular pharmacology [Category] 임상, [키워드] clinical trial Comorbidity complications concept coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 progression Dapagliflozin diabete diabetes Effects epidemiological studies failure Glucose inhibitor respiratory Respiratory failure sodium [DOI] 10.1097/FJC.0000000000001011 PMC 바로가기 [Article Type] Review
Six-Month Survival After Extracorporeal Membrane Oxygenation for Severe COVID-19Observational Study Published on 2021-07-012022-10-05 Journal: Journal of cardiothoracic and vascular anesthesia [Category] SARS, 임상, [키워드] 95% CI acute respiratory distress acute respiratory distress syndrome adopted advanced age age all-cause mortality ARDS arterial pH assessment baseline clinical Community coronavirus disease Coronavirus disease 2019 COVID-19 Decreased ECLS ECMO ECMO therapy evaluated Extracorporeal extracorporeal membrane oxygenation failure female hazard ratio Hospitalization hospitals IMPROVE increased risk measurement Mortality multiple comorbidities outcome oxygen PaO Patient patient selection patients patients died replicated retrospective severe metabolic significantly subset suggested survival rate sustained syndrome the mean treated Trial variable [DOI] 10.1053/j.jvca.2021.01.027 PMC 바로가기 [Article Type] Observational Study
How Do Failed Entrepreneurs Cope with Their Prior Failure When They Seek Subsequent Re-Entry into Serial Entrepreneurship? Failed Entrepreneurs’ Optimism and Defensive Pessimism and Coping Humor as a ModeratorArticle Published on 2021-06-302022-10-30 Journal: International Journal of Environmental Research an [Category] Coronavirus, MERS, SARS, [키워드] ambition assist career ambition caused coping coping humor Coping strategy defensive pessimism and optimism Deleterious emotional entrepreneur exacerbate failure fear of failure humor implication include Intensive Intention Korean mechanism Mental Moderator optimism Pain pessimism prevalent Prevent provide Psychological Stress subsequent [DOI] 10.3390/ijerph18137021 PMC 바로가기 [Article Type] Article
A History of Heart Failure Is an Independent Risk Factor for Death in Patients Admitted with Coronavirus 19 DiseaseArticle Published on 2021-06-302022-10-30 Journal: Journal of Cardiovascular Development and Disease [Category] COVID-19, [키워드] absence age association body mass index cardiovascular disease cardiovascular diseases Clinical severity co-morbidity Comorbidities competing corona virus 2019 Coronary artery disease COVID-19 COVID-19 patient cumulative death demonstrated Diagnosis Ejection fraction Epidemiology event Factor failure heart heart failure history hospital Hospitalization hypertension in-hospital mortality intubation marker mechanical ventilation Mortality need for dialysis no difference Older outcome Patient patients with COVID-19 preserved propensity score matching reduced remained renal replacement therapy risk factor significantly higher statistically significant survival systemic inflammation two group ventricular with COVID-19 [DOI] 10.3390/jcdd8070077 PMC 바로가기 [Article Type] Article
qSOFA score poorly predicts critical progression in COVID-19 patientsOriginal Article Published on 2021-06-292022-10-29 Journal: Wiener medizinische Wochenschrift (1946) [Category] COVID-19, COVID19(2023년), MERS, SARS, [키워드] Österreich acute respiratory syndrome Admission analyzed assessment Austria caused clinical risk coronavirus disease Course COVID-19 Critical death defined disease Disease progression disease status evaluate failure Hospitalized ICU ICU admission impairment IMPROVE Infection intensive care intensive care unit Intensivstation management mortality rate new virus Organ dysfunction scores other diseases oxygen saturation oxygen supplementation Patient pilot study predict progression qSOFA Result risk SARS-CoV-2 Score für Organdysfunktion simple Tod transferred [DOI] 10.1007/s10354-021-00856-4 PMC 바로가기 [Article Type] Original Article
Obesity May Not Be Associated with 28-Day Mortality, Duration of Invasive Mechanical Ventilation and Length of Intensive Care Unit and Hospital Stay in Critically Ill Patients with Severe Acute Respiratory Syndrome Coronavirus-2: A Retrospective Cohort StudyObservational Study Published on 2021-06-292022-10-04 Journal: Medicina [Category] MERS, SARS, 임상, [키워드] 28-day mortality age all-cause mortality assessment association body mass index correlation critically ill patients Duration Factor failure had no hospital Hospital stay ICU Ill independent intensive care unit Invasive mechanical ventilation investigated Kaplan–Meier Length Length of stay log rank material Mechanical multivariate Cox regression obesity Observational cohort study Patient Pneumonia respiratory retrospective RT-PCR SARS-CoV-2 SARS-CoV-2 pneumonia severe acute respiratory syndrome coronavirus-2 significant difference SOFA statistically significant survival the patient [DOI] 10.3390/medicina57070674 PMC 바로가기 [Article Type] Observational Study
Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection RiskCOVID-19 저산소 호흡기로 입원 한 환자에서 고용량 코르티코 스테로이드가있는 저용량 토 실리 주맙Multicenter Study Published on 2021-06-282022-09-01 Journal: The Annals of Pharmacotherapy [Category] MERS, 진단, [키워드] 28-day mortality 95% CI Adult patients adult respiratory distress syndrome Analysis balance benefit Biomarker Combination combination therapies combination therapy Corticosteroid Corticosteroids COVID-19 COVID-19 pneumonia COVID-19 treatment Dexamethasone dexamethasone 6 mg dosage failure group hazard ratio high mortality hypoxia hypoxic respiratory failure Increased Infection Inflammation Interleukins medication therapy management Modification Mortality objective Patient patients with COVID-19 Pneumonia present reduction in mortality Relative risk Relevance respiratory Respiratory failure respiratory infections Result Retrospective study risk risk of infection Secondary infection severe respiratory failure Standard of care steroid supportive therapy survival therapeutic effect therapy Tocilizumab Treatment was performed were assessed [DOI] 10.1177/10600280211028882 PMC 바로가기 [Article Type] Multicenter Study